Corporate News     19-Nov-21
Shilpa Medicare's Unit III R&D facility clears USFDA Remote Record Review
With zero observations
Shilpa Medicare announced that the USFDA has concluded Remote Record Review of Shilpa Medicare ('SML' or 'the Company), Unit III, Research and Development facility situated at Dabaspet, Bengaluru, Karnataka without any objectionable conditions or observations. The review was conducted during 15 to 18 November 2021.

Shilpa Medicare's Unit III, R&D facility is involved in development of formulations (generics, complex generics and innovative products) and providing advanced analytical services.

Previous News
  Sensex declines 150 pts; realty shares slide for 5th day
 ( Market Commentary - Mid-Session 04-Oct-24   10:32 )
  Shilpa Medicare gains as Hyderabad unit clears USFDA inspection
 ( Hot Pursuit - 01-Mar-24   14:47 )
  Shilpa Medicare Ltd leads losers in 'A' group
 ( Hot Pursuit - 29-Dec-23   15:00 )
  Shilpa Medicare consolidated net profit declines 77.35% in the March 2021 quarter
 ( Results - Announcements 31-May-21   16:08 )
  Volumes jump at G R Infraprojects Ltd counter
 ( Hot Pursuit - 14-Jun-22   14:30 )
  Board of Shilpa Medicare to consider preferential issue of equity shares
 ( Corporate News - 12-Oct-21   09:51 )
  Shilpa Medicare launches India's First Women intimate cleansing spray - SwatchShil
 ( Corporate News - 04-Mar-21   11:46 )
  Shilpa Medicare fixes record date for interim dividend
 ( Market Beat - Reports 20-Feb-18   09:29 )
  Shilpa Medicare consolidated net profit rises 51.74% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   15:15 )
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
 ( Hot Pursuit - 05-Jul-24   14:52 )
  Shilpa Medicare consolidated net profit declines 10.70% in the September 2017 quarter
 ( Results - Announcements 13-Nov-17   16:44 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top